Jesse Steinfeld, MD, best known for being during Richard Nixon's first term as president, died Aug. 5 at age 87 from a stroke.
should be used more often for cardiac ultrasound, according to guidelines from the American Society of Echocardiography.
The Centers for Medicare and Medicaid Services finalized its determination that under Medicare only when performed in a registered clinical trial and only for FDA-approved indications.
A transition plan for patients (Coumadin) in the ENGAGE AF-TIMI 48 trial cut excess bleeds and thrombotic events, researchers suggested in the Journal of the American College of Cardiology.
Medtronic's Attain Performa model 4298 quadripolar lead and its Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators received FDA approval, .
The first patient to receive an is a 37-year-old British man, Reuters reported. The news follows Cytori's decision last week to after adverse cerebrovascular events were detected.
Here's a on "a procedure that made sense and had supporting evidence, became common practice, but was later discontinued because a high quality study showed it to be ineffective" -- extra-cranial intra-cranial bypass surgery.
The Transcatheter Cardiovascular Therapeutics meeting have been announced and include the 5-year results of the PARTNER I trial, a cost-effectiveness analysis of the CoreValve High Risk trial and a comparison of 6 versus 12 months of dual antiplatelet therapy after a drug-eluting stent in the SECURITY trial.
CardioBreak is a guide to what's new and interesting on the Web for cardiologists and other healthcare professionals with an interest in cardiovascular disease, powered by the ڴŮ community. Got a tip? Send it to us: c.phend@medpagetoday.com.